EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
  5. Coronavirus, WHO rät von Remdesivir zur Behandlung von Covid-19-Patienten ab

Coronavirus, WHO rät von Remdesivir zur Behandlung von Covid-19-Patienten ab

20.11.2020

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

Bilder in dieser Kollektion

  • 10.09.2020, Pharmaindustrie : Gilead Sciences, Inc., Ein Pharmazie- und Biotechnologieunternehmen aus den Vereinigten Staaten 10.09.2020, Pharmaindustrie 10.09.2020, Pharmaindustrie

    10.09.2020, Pharmaindustrie : Gilead Sciences, Inc., Ein Pharmazie- und Biotechnologieunternehmen aus den Vereinigten Staaten 10.09.2020, Pharmaindustrie 10.09.2020, Pharmaindustrie

  • Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

    Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

  • Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

    Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

  • Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

    Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

  • Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

    Spritze und Remdesivir-Schriftzug, Wirkstoff Remdesivir gegen Corona-Infektion

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909648x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909648x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909647x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909647x CaduxRolim

  • SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909643x CaduxRolim

    SOROCABA, SP - 03.05.2020: REMDESIVIR É NOVA ESPERANÇA PRA COVID19 - Conceptual photo of the antiviral remdesivir (GS-5734), a drug that originally treats hepatitis and common respiratory viruses. The American Food and Drug Administration (FDA) recently issued a temporary emergency approval to remdesivir it as treatment for critically ill patients with COVID-19 (new coronavirus). x1909643x CaduxRolim

  • 01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

    01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

  • 01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

    01-05-2020 Gilead has demonstrated that Remdesivir is active against the virus that causes COVID-19 (c) PPE Beijersbergen The Hague The Netherlands Copyright: xPPEx

Kollektionen
Auswahl